Corrigendum to “Relating TMS measures of GABAergic and Cholinergic signalling to attention” [Brain Stimul 18 (1) (2025) 507–508, (S1935861X24010489), (10.1016/j.brs.2024.12.853)]
Frangou P., Foster L., Ferrandes F., Heaney S., Robinson B., Rahimi N., Ratcliffe Y., Stagg C.
The authors regret that some of the authors are omitted in the original publication. The correct list of authors is as presented above. The authors also regret the errors in the abstract text. The corresponding corrections are provided below: The first line of paragraph 3 of the abstract should read: Here we investigated the role of GABA and ACh in healthy vision (n = 35). The last two paragraphs of the abstract should read as follows: We found that higher GABAergic Cholinergic inhibition in the motor cortex relates to better orienting attention allocation, as indicated by a significant correlation between the alerting orienting index of the ANT and SICI-1msSAI (r = −0.5942, p = 0.004). Despite the proposed role of Cholinergic signalling024). Our results are in line with evidence suggesting cholinergic mechanisms are responsible for successful orienting of attention, we did not find a significant correlation between SAI and any of the attentional indices (alerting, orienting, executive) of the ANT. Our findings suggest that GABAergic Cholinergic inhibition plays an important role in success fulorienting attention allocation and have guided the design of our ongoing pharmaco-TMS study investigating the effects of Zolpidem (GABA agonist) and Donepezil (cholinesterase antagonist) on behavioural and neurophysiological indices of attention. The authors would like to apologise for any inconvenience caused.